生命科学资讯

Sanofi's troubled GCS inhibitor fails phase 3 Fabry trial but scores in Gaucher disease

AstraZeneca study finds 22 genes tied to chronic disease risk after Epstein-Barr infection

Pharming’s immunodeficiency drug gets CRL for use in younger patients

National Pension Service Acquires 11,841 Shares of Agilent Technologies, Inc. $A - MarketBeat

Principal Financial Group Inc. Sells 626,401 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Thrivent Financial for Lutherans Sells 38,212 Shares of Illumina, Inc. $ILMN - MarketBeat

Building a robust in-process testing plan for cell therapy manufacturing success

Y Intercept Hong Kong Ltd Cuts Stock Position in Illumina, Inc. $ILMN - MarketBeat

Mawer Investment Management Ltd. Acquires 1,074,449 Shares of Waters Corporation $WAT - MarketBeat

Principal Financial Group Inc. Purchases 46,339 Shares of Waters Corporation $WAT - MarketBeat

Lonza Group AG: The Silent Engine Powering the Next Wave of Biotech - AD HOC NEWS

European law changes mean drugmakers may have to grapple with generic competition sooner

Thermo Fisher Reworks Operations While Targeting Growth In Clinical Data - simplywall.st

MRI sets its sights on collagen

Assessing Illumina (ILMN) Valuation As Shares Rebound But Long Term Returns Remain Under Pressure - Yahoo Finance Singapore

Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in 10x Genomics $TXG - MarketBeat

AlphaQuest LLC Increases Holdings in 10x Genomics $TXG - MarketBeat

Is Thermo Fisher Scientific (TMO) Pricing Reflect Its Recent Share Pullback And DCF Estimate - Yahoo Finance

Mediolanum International Funds Ltd Purchases 65,353 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Strs Ohio Cuts Holdings in Waters Corporation $WAT - MarketBeat